Type 4 renal tubular acidosis (hyperkalaemic)
Acid-Base · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Hypoaldosteronism or aldosterone resistance causing a normal anion-gap metabolic acidosis with hyperkalaemia; commonly in diabetic nephropathy and with certain drugs.
Red flags
- Hyperkalaemia with ECG changes
- Significant acidosis
- Coexisting AKI
- Cardiac arrhythmia
Assessment
Differential diagnosis
- Type 1/2 RTA
- CKD hyperkalaemia
- Adrenal insufficiency
- Drug-induced hyperkalaemia
- Pseudohypoaldosteronism
Investigations
- U&E, potassium, bicarbonate, chloride, VBG
- Urine pH (usually <5.5) and urine electrolytes
- Glucose/HbA1c (diabetes)
- Review medications (ACEi/ARB, spironolactone, NSAIDs, trimethoprim)
Management
- Confirm hyperkalaemic normal anion gap acidosis
- Treat significant hyperkalaemia acutely
- Stop or reduce culprit drugs (ACEi/ARB, potassium-sparing diuretics, NSAIDs)
- Low-potassium diet and loop diuretic to promote kaliuresis
- Fludrocortisone in selected hypoaldosterone patients
- Sodium bicarbonate for persistent acidosis
Drugs & doses
Acute hyperkalaemia treatment as needed
Loop diuretic (promotes potassium loss)
Fludrocortisone (selected cases)
Sodium bicarbonate for acidosis
Stop offending drugs
Disposition
Admit if hyperkalaemia significant; nephrology follow-up.
Complications & pitfalls
- Life-threatening hyperkalaemia
- Arrhythmia
- Progressive CKD
Exam pearls
- Unlike other RTAs, this one causes hyperkalaemia
- Very common in diabetic nephropathy
- Drug review often resolves the problem
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.